Abstract
The oral drug delivery market is the largest segment of the drug delivery market, and there' s no sign that it is slowing down. With pharmaceutical companies increasingly turning to drug delivery to extend the revenue-earning lifetime of their biggest products, find a convienient form and market acceptance of new biopharmaceuticals, and tap into the growing elderly population that requires products with a level of ease-of-use and cost benefit, it' s no surprise that the oral delivery drug market is a $35 billion industry and expected to grow as much as ten percent per year.
Kalorama' s Drug Delivery Markets. Edition 2 Volume I: Oral Delivery, the first volume of Kalorama' s popular series focusing on drug delivery systems, provides the definitive break down of the market for oral delivery drug markets. The report covers both the major technologies in oral delivery (controlled-release, delayed release, pulsatile-release, taste-masked and microemulsion formulations) and the products that use these delivery technologies.
In the reporting of market size and growth through 2010, Kalorama' s uniques analysis also separates the value of the technology portion of the market from the active ingriedient portion of the market, allowing for a deeper understanding of the value of the market attributable to the delivery technologies themselves.
This focused report provides information on the revenues for relevant companies and provides information critical to assessing the opportunities available in this market, including:
- Legacy Companies in Oral Delivery as well as Recent Entrants
- Current Market Share for Companies and Future Forecasts
- Challenges Faced by Oral-Delivery Technology Companies
- Success Stories and Pitfalls.
- The Trends That are Expected to Lead to Growth
Kalorama' s trusted information-gathering process provides most accurate study of the oral delivery drug market available today. Information and analysis presented in this report is based on extensive interviews with senior management of top companies in the industry. While major research literature and government information is culled, information is corroborated and key market insights originate from interviews with industry leaders.
Product managers, marketing managers, business development executives, advertising agency or investment firm executives, and information and research center librarians are among the individuals who will find this report on the oral delivery drug market essential.
Table of Contents
Chapter one: Executive Summary
- Market Drivers
- Market Size and Growth
- Total Oral Drug Delivery Market
- Oral Drug Delivery Technology Only Market
- Competitive and Market Analysis
Chapter two: Introduction and Overview
- Scope of the Report
- Methodology
- History of Oral Drug Delivery
- Phases of Drug Action
- Barriers to Oral Drug Delivery
- Controlled-Release/Sustained-Release
- Delayed Release and Modified Release
- Fast Dissolving
- Taste-Masked
- Pulsatile Release
- Microemulsion and Others
Chapter three: Key Trends and Demographics
- The Elderly
- Regulatory Environment
- Patent Protection and Extension
- Earlier Involvement
- Consolidation
- Proprietary Product Development
- Implications for Generic and Over-the-Counter Products
- Pharmaceutical Formulation
Chapter four: New Developments
- Macromolecule Delivery
- Delivery of Hydrophobic Drugs
- Other Delivery Solutions
Chapter five: Market Size and Growth
- The Total Oral Drug Delivery Market
- Oral Delivery Technology Only Market
Chapter six: Competitive Analysis
- Competitive Landscape
Chapter seven: Company Profiles
- ALZA Corporation
- Andrx Pharmaceuticals
- Biovail Corporation
- Cardinal Health
- Elan Corporation, plc
- Emisphere Technologies, Inc.
- KV Pharmaceutical
- Labopharm, Inc.
- Penwest Pharmaceutical Company
- Purdue/MundiPharma/Napp Group
- SkyePharma PLC
Chapter eight: Companies in Brief
- Alkermes, Inc.
- Astellas
- BioProgress Technologies International, Inc.
- CIMA Labs, Inc. Division of Cephalon
- DepoMed, Inc.
- Endorex, Inc.
- Eurand, Inc.
- Kos Pharmaceuticals, Inc.
- Lipocine, Inc.
Appendix: Company Directory
List of Exhibits
Chapter one: Executive Summary
Chapter two: Introduction and Overview
- Table 2-1: Selected Types of Oral Solid Preparations
- Table 2-2: Sequence of Drug Action
Chapter three: Key Trends and Demographics
- Table 3-1: World Population by Age Group 2002-2010
- Figure 3-1: World Population by Age Group 2002-2010
- Table 3-2: Recent Consolidations in the Drug Delivery Market
Chapter four: New Developments
Chapter five: Market Size and Growth
- Table 5-1: The Worldwide Market for Oral Drug Delivery Technology and Pharmaceuticals Revenues and Growth Rate 2002-2010
- Figure 5-1: Trending in the Worldwide Market for Oral Drug Delivery Technology and Pharmaceuticals 2002-2010
- Table 5-2: The Worldwide Market for Pharmaceuticals Utilizing Oral Drug Delivery Technologies by Type 2002-2010
- Figure 5-2: Trending in the Worldwide Market for Pharmaceuticals Utilizing Oral Drug Delivery Technologies by Type 2002-2010
- Table 5-3: The Worldwide Market for Pharmaceuticals Utilizing Oral Drug Market Share by Type 2002-2010
- Table 5-4: The Worldwide Market for Oral Drug Delivery Systems by Pharmaceutical vs Drug Delivery Components 2002-2010
- Table 5-5: The Worldwide Market for Oral Drug Delivery Systems Distribution of Revenue by Pharmaceutical vs Drug Delivery Component 2002-2010
- Figure 5-3: The Worldwide Market for Oral Drug Delivery Systems Share of Revenue by Pharmaceutical and Drug Delivery Component 2006, 2010
Chapter six: Competitive Analysis
- Table 6-1: Leading Suppliers of Oral Drug Delivery Technology (Company, Proprietary Technology, Approved Products)
